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To identify genes involved in morphogenetic events during mouse ovary development, we started with microarray analyses of whole
organ RNA. Transcripts for 60% of the 15,000 gene NIA panel were detected, and about 2000 were differentially expressed in nascent
newborn compared to adult ovary. Highly differentially expressed transcripts included noncoding RNAs and newly detected genes involved
in transcription regulation and signal transduction. The phased pattern of newborn mouse ovary differentiation allowed us to (1) extend
information on activity and stage specificity of cell type-specific genes; and (2) generate a list of candidate genes involved in primordial
follicle formation, including podocalyxin (Podxl), PDGFR-h, and a follistatin-domain-encoding gene Flst1. Oocyte-specific transcripts
included many (e.g., Deltex2, Bicd2, and Zfp37) enriched in growing oocytes, as well as a novel family of untranslated RNA’s (RLTR10) that
is selectively expressed in early stage follicles. The results indicate that global expression profiling of whole organ RNA provides sensitive
first-line information about ovarian histogenesis for which no in vitro cell models are currently available.
Published by Elsevier Inc.
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Introduction Experimental embryology has inferred that the perinatalMammalian ovary development coordinates complex
molecular, cellular, and histogenetic events. Contrary to
testis differentiation, where germ cells are dispensable,
oocytes are required to induce ovarian somatic cells
(McLaren, 2000). In turn, the accretion of somatic cells
around the oocytes forms primordial follicles that preserve
the oocyte pool (Ohno and Smith, 1964; Peters, 1969).
Subsequently, primordial follicles are recruited to grow.
Initially controlled by local intercellular signaling, they later
respond to additional regulation of selective ovulation by
the hypothalamic–pituitary axis.0012-1606/$ - see front matter. Published by Elsevier Inc.
doi:10.1016/j.ydbio.2004.11.029
* Corresponding author. Fax: +1 410 558 8331.
E-mail address: schlessingerd@grc.nia.nih.gov (D. Schlessinger).
1 These authors contributed equally.
2 Current address: Programa de Gene´tica Humana, ICBM, Facultad de
Medicina, Universidad de Chile, Santiago, Chile.formation of follicles and the reorganization of the ovary
into morphological compartments (bcortexQ and bmedullaQ)
are required to prevent the otherwise massive derepressed
growth of ovarian follicles (Byskov et al., 1997 and
references therein). Consistent with these findings, we have
shown that in mice lacking the Foxl2 transcription factor,
deregulated oocyte growth (Schmidt et al., 2004) follows a
primary impairment of follicle formation and ovarian
histogenesis (Uda et al., 2004).
In the mouse model, numerous other factors have been
identified that directly affect primordial follicle formation
(Fig-a, Liang et al., 1997; Soyal et al., 2000; Dean, 2002;
Wnt4, Vainio et al., 1999; TrkB, Spears et al., 2003; NGF,
Dissen et al., 2001) or the related progression into prophase
of meiosis I (Dazl, Ruggiu et al., 1997). Other genes are
required earlier for the establishment of the germ cell pool
(c-kit/Steel, Zfx, Elvin and Matzuk, 1998), or at later stages279 (2005) 271–290
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growth. Growth is regulated locally (Gdf9, Lif, and Bmp15;
Elvin et al., 1999; Yan et al., 2001) or in response to
pituitary endocrine factors (Fshr, Lhr, Elvin and Matzuk,
1998). Still other factors promote growth (e.g., cyclin D2) or
regulate apoptosis (e.g., caspase-9 and-2, and bcl-2 gene
family members; reviewed by Pru and Tilly, 2001; Reynaud
and Driancourt, 2000).
To help assess the full range of genes involved in follicle
development, we have turned to a global genomic approach.
Nascent primordial follicles occupy most of the organ at
birth, but constitute only a marginal fraction of the adult
ovary. This makes parallel gene expression profiling on
whole organs with microarrays of cDNAs a useful way to
infer genes that are active specifically during primordial
follicle formation. A comparable whole organ approach was
recently used to study stages of spermatogenesis (Fujii et al.,
2002) and molecular anomalies in ovaries of mice lacking
Fsh-h (Burns et al., 2001). Here we infer that at least 9000
transcripts were expressed during mouse ovary formation.
Many showed developmentally regulated transcription. In
addition to transcripts already known to be involved in
ovary development, they included novel untranslated RNAs
and mRNAs for signaling and transcription factors that had
not previously been detected in the ovary. We used further
experiments and complementary information to assign cell
and stage specificity to selected transcripts.Methods
Probe preparation and microarray hybridization
Animals were euthanized ethically according to ACUC-
approved NIA Animal Protocols. Total RNA samples from
C57BL/6J mice were used for microarray hybridization and
quantitative real-time RT-PCR. Mouse tissues were sampled
and immediately rinsed with phosphate-buffered saline
(PBS) and frozen on dry ice. Trizol (Life Technologies)
was used to isolate total RNA. For real-time PCR, the RNA
samples were treated with bRNase-free DNaseQ (Boehringer
Mannheim, Mannheim, Germany) to eliminate genomic
DNA contamination. Total RNAs from adult ovary (4–6
months) were used in real-time RT-PCR experiments. The
mouse NIA 15K gene set (15,264 rearrayed unique genes or
gene isoforms), printed on seven nylon membranes, was
used in hybridizations (Tanaka et al., 2000). Sequence
information is available at http://www.ncbi.nlm.nih.gov/ and
at the National Institute on Aging web site http://lgsun.grc.
nia.nih.gov/. The cDNA clone identification, for example,
H3146E11, is the ID code used in the NIA 15k gene set
(Tanaka et al., 2000).
Three cDNA samples were prepared for adult (4–6
months old) and newborn ovary (2–3 days postnatum). The
template for cDNA synthesis was 3.4 Ag of total RNA using
SuperScript II reverse transcriptase with oligo(dT) primer.Of the amplified cDNA, 2.1 Ag was used as substrate to
incorporate [a-33P]dCTP (Amersham Pharmacia Biotech
Inc, Piscataway, NJ, USA) by random priming (RadPrime
DNA labeling system, Life Technologies). The DNA probes
were then purified on Quick-spin Sephadex G25 columns
(Roche Diagnostics). Prehybridization and hybridization
were done as in Tanaka et al. (2000). Results from three
independent hybridizations were obtained for each probe.
Images were analyzed by Imagequant 5.0 (Amersham
Pharmacia).
Analysis of data
We used several current analytic methods for the analysis
of gene expression profiling data, focusing primarily on
genes differentially expressed in newborn compared to adult
ovary.
Normalization and analysis of expressed and differentially
expressed genes
Statistical analysis of microarray experiments is much
affected by the preliminary step of normalization of data,
which is required to remove systematic variations in signal
intensity (e.g., Park et al., 2003). We used several standard
approaches to optimize the sensitivity and specificity of
inferred lists of expressed genes, as follows. First, back-
ground was subtracted by linear interpolation of local values
determined at 432 widely distributed microarray filter
locations that bore no DNA. Similar to previous analyses
based on the same arrays (Cui et al., 2002), the intensities
were sum normalized and a threshold value of 100,000
arbitrary units on average across replicates was used as an
inclusion criterion. (This corresponds to 1.5 times average
background after normalization, a level at which signals are
clearly visible by eye on microarray images.) In addition,
the lowest values corresponding to 4% of the total (3247 of
91,488) were replaced by surrogate values using a con-
servative method (baverage row imputerQ, as in the option of
the SAM program; Tusher et al., 2001, and http://www-
stat.stanford.edu/~tibs/SAM/).
Next, to normalize sample variance across experiments,
we separately applied two standard methods, both available
in the Focus program (Cole et al., 2003), to the trimmed,
sum-normalized data set. In one, a modified Z trans-
formation assigned to all replicates the same mean as the
mean value and the same standard deviation (SD) as the
mean SD across all data sets. This preserves a metric, based
on intensities, that is similar to the original data. In a second
method, a tool to deal with overall data variability (Sidorov
et al., 2002), rank normalization, was used to assign the rank
of each gene (from 1 to n) as the ranked value for that gene
in each replicate. This approach emphasizes relative
expression levels rather than actual intensities. (We also
tried direct normalizations by global scaling approaches
(Kroll and Wolfl, 2002), but they gave less sensitivity for
the recovery of known positive clones than the other
Table 1
Specificity and sensitivity of inferred differentially expressed genes
Samples Normalization Specificity
Merged (Nb + Ad) Modified-Z 66/70 (97%)
Rank 40/54 (74%)
Merged 83/105 (79%)
Samples Normalization Sensitivity
Newborn (Nb) Rank 227/538 (42%)
Modified-Z 93/538 (17%)
Adult (Ad) Rank 173/629 (27%)
Modified-Z 320/629 (51%)
Merged (Nb + Ad) Rank 400/1167 (34%)
Modified-Z 413/1167 (35%)
Merged 600/1167 (51%)
Internal consistency of the lists of differentially expressed genes based on
redundant UniGene clusters in the NIA 15K data set (see Methods).
Calculations were done for each of two normalization methods for newborn
and adult (Focus software, see Methods), and for a merged set of clones.
The merged set produced the total of 2247 clones differentially expressed
(Web Tables B and C, and see text). Upper panel: specificity is calculated as
the fraction of UniGene clusters with clones assigned to the same
developmental stage, among the total number of UniGene clusters with at
least two clones being differentially expressed. Lower panel: sensitivity is
calculated as the number of clones that have been detected divided by the
total number of clones that belong to detected UniGene clusters.
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extensively, but each added some clones to a merged list
(see below). The resulting data set is given in WEB Table 1.
Based on amplified cDNA probes from newborn and adult
ovary, 9582 clones (~60% of the total) showed mean
expression intensities above background in newborn ovary,
adult ovary, or both.
Genes differentially expressed in newborn or adult ovary
were inferred from the total list with the Focus implemen-
tation of a PRIM algorithm for microarray analysis (Cole et
al., 2003). The approach mimics human analysts’ inferences
about reliability of expression differences, employing both
raw intensities and ratios of values controlled by an explicit
statistical criterion. Selection of differentially expressed
genes was based on Boolean rules of minimal fold ratio and
mean raw unit differences, optimized for 60% reliability in
predicting 1.5 mean fold changes in normalized data sets.
This is equivalent to setting a 40% false discovery rate
(FDR, as in, e.g., Storey and Tibshirani, 2003), a standard
estimate of the proportion of false positives expected from
repeated experiments. The validation we performed (see
below) indicates that this FDR value actually reflected a
lower fraction of false positives (20%), as calculated from
the redundant clones in our data set. This is consistent with
reported simulations (Cole et al., 2003). The hits in WEB
Tables 2 and 3 are ordered according to their score (a
measure of the normalized distance from the mean for four
parameters of interest) as calculated by Focus.
In simulations, Focus outperformed other commonly used
analytical tools (e.g., Tusher et al., 2001) in its ability to
detect higher numbers of known true positives while
maintaining comparably high specificity (Cole et al., 2003).
For the sets of genes inWEB Table 1, we selected significant
genes as those inferred with the modified Z transformation
because of its very high specificity and sensitivity. That
group was augmented 19% by merging it with the list
recovered by rank normalization, thereby including many
redundant clones with consistent expression, as follows.
Critical controls for internal consistency were provided by
transcripts redundantly represented on microarray mem-
branes. Based on NIA annotations, 1534 mouse UniGene
clusters are represented by at least two clones in the 15K
microarray, amounting to 23% of the total. The transcripts
with at least two clones among those called significant were
classified as consistent (those where all clones had been
assigned to one ovary stage) or inconsistent (those with
assignments to both stages). Using this approach (Table 1),
with z transformation, we obtained 97% specificity (equiv-
alent to 3% FDR) and 57% sensitivity (a total of 1582
differentially expressed clones, 471 of them in newborn
ovary). With rank normalization, 74% specificity was
obtained, with 35% sensitivity (a total of 1316 clones, 323
in the newborn). Merging the results from the two approaches
(see above) yielded 80% specificity and 50% sensitivity
overall. The high specificity for this large number of
significant calls supports the quality of the merged set, withan inferred total of 2247 differentially expressed transcripts
(assembled into 2115 UniGene clusters). Of these, 889 (850
UniGene clusters) are more highly expressed in newborn
ovary. Fig. 1 shows overall distributions. The resulting full
lists of genes are in WEB Tables 2 and 3, and subsets of
selected genes are in Tables 2–4 (see Results).
Validation of microarray expression profiling
In addition to Northern blot hybridization (Results, Fig. 2)
and agreement of values for redundant clones, high-level
expression of genes was preliminarily validated by other
available data. The NIA 15K array was recently used to
compare ovary expression profiles of normal and FSH-h
null mice, detecting 13 differentially expressed genes (Burns
et al., 2001). Because Fsh is required from the preantral
follicle stage to ovulation, the differentially expressed genes
should be upregulated in adult ovaries; and consistent with
that notion, six of these genes were found differentially
expressed in our analysis, all of them in adult ovary (Star,
Hsd3b1, Cyp11a, Ldh2, Tagln, Rbbp7). Similarly, adult
ovary showed enrichment for 11 of 27 genes differentially
expressed in granulosa cell tumors associated with loss of
function of Inha (Burns et al., 2001). This is consistent with
their direct or indirect role in granulosa cell proliferation,
which is suspended neonatally during the process of follicle
formation (e.g., Rajah et al., 1992). Only 1 of the 27 genes
(damage-specific DNA binding protein, Ddb1) was scored
as upregulated in our newborn ovary sample.
Gene ontology and INTERPRO analysis
For global functional classification, a publicly available
package to map UniGene clusters to the Gene Ontology
Fig. 1. Scatter plot of mean intensity adult/newborn log ratio ( y-axis) vs. log of the geometric mean intensity (x-axis) for the entire data set (A) and for the
significant hits detected using two normalization methods (modified Z and rank normalization, C and D, respectively, as well as the merged set of significant
hits, B; see Methods).
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abundant entries in either newborn or adult ovary according
to standard Gene Ontology classification (Fig. 3A). In aTable 2
Functional classification of inferred differentially expressed genes
Annotated genes Newborn
Examples
Apoptosis Casp3, Zac1, Tia1, F830014G06 (Riken)
Immune system –
Oxidative stress –
Steroidogenesis –
Transcription Sox4, Sox15, Nobox/Og2x, Psx1, Pknox1/Prep1, Meis1,
Idb1, Trim28, Tceb1l, Mcmd5, Hmga1, Hmgb3, Polr2a,
C76800, Ankrd6, Preb, Taf7, Taf7L, Mllt10, Polr2j,
Ldb1, Phtf, 1500004O14, 9830141C09(Riken), Supt4h,
Gtf2h1, Ubp1, Stat3, Psmd10, Cnbp, Gtf2b, Stat3, Pole4,
Ccnc, Hdac2, Dnmt3a, Nr2f2, Hmga2, Pole4, E2f6,
Mycbp, 5730434I03(Riken), Lztr1, Usf1, Hdac3
RNA binding
proteins
1200009K13(Riken), Tarbp2, Raly, D11Ertd619e, Sfrs3,
G3bp2, 1200009K13Rik, Supt6h, Zfr, Eif4e, U2af1,
Eif4g2, Slbp, Fmr1, Ps1d, Tia1, Dazl, Stau1, Ssfa1
Secreted factors Npnt, Podx1, Ag2R2, Wnt4, Wnt2, Semaphorins-6a, -4g,
Itgb7, Ptn, P4hb, Igf2, Igfbp5, Spon2, Prss15, Abcd3, Tem
Cd97, Serpina6, Akp5, Acadl, Timd2, Entpd2, Tparl, Mesp
Cytoplasmic factors Apc, Nras, Ralgds, Rtn4, CK18, CK19, CK8
Functional classification of selected differentially expressed genes classified into s
(apoptosis, immune system, oxidative stress, steroidogenesis) categories accordincomplementary approach, protein domain information was
derived from the NIA GeneIndex (http://lgsun.grc.nia.nih.
gov/geneindex/) and a combined search through INTER-Adult
Gpx1, Bag3–4, Gadd45g, Tnfrsf12a, Bcl2l10, Cul1, Mcl1, Sgk,
Tpt1, App, scotin, Trp53, Dad1, Ngfrap1
C1qr1, C1qb, MyD88, ID_B1, B2_Mm2, H2-Eb1
Gpx1, Prdx1, Sod1
Cyp11A1/P450ssc, Cyp17, StAR, Hsd3b
SF1, Gli2, Hoxc9, Onecut1, Gata2, Fosl1, -2, Heyl, 2610103K11Rik,
Fhl2, Sh3d3, Rabl3, Irf1, Runx2, D15Ertd417e, Atf3, Nfe2l2,
A730098D12(Riken), Tef, Polr2c, Copeb, Nrf1, Tgfb1i4, Foxo1,
Tgfb1i4, Myc, Baz1a, Tgfb1i4, Rpo1-1, Cbfa2t1h, Paf53, Ankrd106,
Hif1a, Hmgb2, Tcf4, Atf2, Cnot8, Rab7, Tcfe2a, Aes, Trp53, Mcmd
Hnrpdl, Srp19, C81487, 2310046H11Rik, Snrpb2, G3bp, Srp9,
Hnrpa1, Ddx1, -5, Rps14, Rps27, Sfrs2, Park7
8,
2
Zp3, Pecam, Sel1, Eg1, Gdf9, Bmp15, TGFbeta2 Ctsl, Robo1, Ctsb,
Itgb5, Cst3, Gm2a, Sdf4, Gpx3 Serpine2, Frk, Dpp7, Cdh1, Scg3,
Cd8b, Serpinh1, Inha, Ecm1, C1qb, C1qr1, Plxna3, Lrp1, Col4a1, -2
Rassf5, Jak1
tructural (transcription, RNA binding, cytoplasmic, secreted) and functional
g to annotations from Gene Ontology, Riken, and NIA databases.
Table 3
Genes preferentially expressed in oocytes, inferred frommicroarray data as inWEB Tables 2 and 3 combined with information from EST libraries (see Methods)
NIA clone ID ESTs Gene/UniGene/Riken Annotations
Egg NbOv p
A. Inferred oocyte-enriched genes expressed throughout oogenesis
H3028B04 58 0 0 1700022N24 IPR001841 Zn-finger, RING, C3HC4
H3092A01 53 0 0 Chek1 checkpoint kinase 1 homolog (S. pombe)
H3071A11 50 1 0 G3bp2-pending Ras-GTPase-activating protein SH3-binding rotein 2; RRM domain
H3014B10 36 4 0 Ncl nucleolin
H3113A01 28 1 0 Slbp stem loop binding protein
H3075B10 24 0 0 2810404F18 PAK-box/P21-Rho-binding; non-kinase CDC42 effector
H3102E07 17 0 0 Mater maternal effect gene
H3074F07 20 1 0.001 Usp7 Ubiquitin thiolesterase, family 2; IPR002083
H3059G02 14 0 0.001 Mm.222875 Intron-containing, no long open reading frame,
no similarity by BlastX
H3076A09 13 0 0.002 Mllt10 myeloid/lymphoid or mixed lineage-leukemia translocation 10
H3152D10 13 0 0.002 0610039L19 dTDP-4-dehydrorhamnose reductase
H3076G12 10 0 0.009 C430041I18 Similar to hypothetical protein MGC4039
H3032A06 8 0 0.022 Pabpc4 RRM and polyA-binding
H3074A05 14 2 0.027 Prc1 protein regulator of cytokinesis 1-like (LOC233406)
H3091D12 7 0 0.036 Golph2 Mak10 subunit, NatC N/alpha-terminal acetyltransferase
H3093E01 7 0 0.036 Rtn4 reticulon 4/Nogo (also found in somatic tissues)
H3140E07 7 0 0.036 2410017P07 Uncharacterized "DUF1167" domain encoding protein
H3121D01 9 1 0.061 Pole4 DNA polymerase epsilon 4 (p12 subunit) (also, H3126A12)
H3125E11 9 1 0.061 P4hb disulfide isomerase
H3140F04 2 5 0.077 Anxa6 annexin A6 (Anxa6)
H3005C12 7 1 0.13 Trim28 tripartite motif protein 28; TIF1-beta; KRIP1
H3140G02 7 1 0.13 Pes1 pescadillo homolog 1, containing BRCT domain
H3123C01 2 4 0.151 D0H4S114 DNA segment, human D4S114
H3130A05 1 3 0.156 Psmd2 proteasome 26S subunit, non-ATPase, 2 (Psmd2)
H3134F02 1 3 0.156 Mm.15755 A130024G22 Riken: transcriptional regulator, SIN3A/yeast
H3136A02 6 1 0.188 Sh3d1B SH3 domain protein 1B
H3071G01 5 6 0.202 AA407558/Mm.245522 Ankyrin repeat domain protein 17
H3081F02 8 2 0.203 Eif4enif1 translation initiation factor 4E nuclear import factor 1
H3157H12 8 2 0.203 Rock1 Rho-associated coiled-coil forming kinase 1
H3149E08 13 5 0.265 Anxa7 annexin A7 (Anxa7)
H3030C03 2 3 0.282 2610511G16 IPR003034 DNA-binding SAP
H3140F06 9 8 0.294 P5-pending disulfide isomerase A6 P
H3081E09 1 2 0.322 Tp120a-pending TBP-interacting 120
H3147B01 1 2 0.322 Tyro3 protein tyrosine kinase 3
H3137B11 4 4 0.358 Mest mesoderm specific transcript
H3073F11 6 2 0.361 Simp-pending 1300006C19 Riken; IPR003674 Oligosaccharyl transferase
H3117B10 6 2 0.361 2310046H11 RRM-encoding
H3036G12 4 1 0.374 Krt2–8 ? PR000719 Protein kinase; IPR003054 Type II keratin;
H3081C01 3 3 0.412 2810411G23 2810411G23Riken, similar to Tumor protein D52
H3140E04 2 2 0.488 Hcph hemopoietic cell phosphatase
H3033A12 4 3 0.534 1110061O04 en tyrosine specific and dual specificity phosphatase
H3119C06 1 1 0.614 Nol5 nucleolar protein 5
H3131B12 1 1 0.614 5730434I03 BTF3 transcription factor
H3142G03 1 1 0.614 Ddb1/Dnajc3 DnaJ (Hsp40) homolog, subfamily C, member 3
H3144A01 1 1 0.614 Mm.103143/325551 Alanine-rich region/Type I antifreeze protein containing protein
H3146G11 1 1 0.614 MGC11792 Similar to Inversin
H3157E01 1 1 0.614 D030016E14 OVARC1001768
H3024G11 1 1 0.614 4833420O05 hypothetical Ubiquitin carboxyl-terminal hydrolase family 2
H3024E01 2 1 0.678 MGC19382 PR001026; Phosphatidylinositol binding clathrin assembly
H3130E06 2 1 0.678 H19 Untranslated RNA (also H3130H06,H3140G12)
H3134D02 2 1 0.678 2610511O17 2610511O17 Riken
H3076B02 2 1 0.678 Zfr zinc finger RNA binding protein
H3145H09 2 1 0.678 Prdx4 peroxiredoxin 4 (Prdx4)
B. Inferred oocyte-enriched genes expressed in growing oocytes
H3056F01 178 0 0 Gdf9 Growth differentiation factor 9 (also H3053D04)
H3079C07 92 0 0 Rhpn2 GTP RHO binding protein
H3031C11 35 0 0 Myo10 Myosin X
(continued on next page)
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Table 3 (continued)
NIA clone ID ESTs Gene/UniGene/Riken Annotations
Egg NbOv p
B. Inferred oocyte-enriched genes expressed in growing oocytes
H3004E12 34 0 0 Dtx2 Deltex2 (Notch pathway)
H3068G09 31 0 0 Spin Maternal transcript Spindlin
H3065G04 27 0 0 Prostein-pending Rieske iron-sulfur protein (also H3066G04)
H3146F12 26 2 0 2700023B17 C19orf13 protein (AlphaSNBP(B))
H3052A09 24 0 0 E330034G19 Aldehyde dehydrogenase-domain
H3042G08 22 0 0 Gpr108 Lung seven transmembrane receptor 2
H3056E04 21 0 0 4921517A06 IPR007527 SWIM Zn-finger
H3122F01 19 0 0 Atp5b ATP synthase, H+ mitochondrial F1 complex
H3056E09 17 0 0 Zfp37 KRAB-box zinc finger
H3023D06 15 1 0.005 Pgk1 phosphoglycerate kinase 1
H3103E12 12 0 0.003 Bcl2l10 Bcl2-like 10 (also H3058C03)
H3070C09 9 0 0.014 Mm.222875/Mm.333241 Intron-containing; no ORF
H3054E08 9 0 0.014 D1Ertd251e 2900026B15 Riken
H3052D01 9 0 0.014 6330415M09 hypothetical Doublecortin (also H3055A02)
H3068E12 8 0 0.022 Cul1 SCF E3 ubiquitin ligase complex
H3066G06 8 0 0.022 LOC234699 Human autoantigen Ge-1
H3056G11 8 0 0.022 Nub1 NEDD8 ultimate buster-1 (BS4 protein)
H3055A10 8 0 0.022 Tef Cytosolic phospholipase A2
H3006A06 8 0 0.022 Surf4 Surfeit gene 4
H3055E09 8 0 0.022 E130301L11 Tastin/Trophinin assisting
H3129A03 11 1 0.027 2410073G16 Similar to KIAA0261 [Homo sapiens]
H3122D01 7 0 0.036 Nedd4 Ubiquitin-protein ligase
H3109D02 7 0 0.036 4930504E06 NF-E2 inducible protein
H3054G09 7 0 0.036 Banp Btg3 associated nuclear protein
(A) Newborn enriched: expressed at high levels in ovulated eggs but also showing higher relative expression in newborn ovary microarray because of the
dilution of oocytes in adult ovary. (B) Adult enriched: growing oocyte markers (expression is higher in adult ovary microarray and in egg EST library than
newborn microarray and EST library, respectively). These genes were determined by combining EST library information (unfertilized egg and newborn ovary)
with microarray data. The numbers of ESTs detected and P value for the comparison between EST libraries are given.
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go.jp). The 15K clone sequences were mapped onto the
RIKEN database (60,770 sequence assemblies) under
stringent criteria: matches with high sequence identity
over regions compatible with the length and sequence
errors typically detected in EST sequences, that is, 95%
identity over 40 nucleotides. The RIKEN annotations
provide links to the encoded protein sequences according
to the Trembl nomenclature (fantom2.gsc.riken.go.jp,
Carninci et al., 2003), and the latter is separately linked
to INTERPRO protein domain annotations (ftp.ebi.ac.uk/
pub/databases/interpro). A data set assembling this infor-
mation was created, and the top-ranking protein domains
were sorted for both the newborn and the adult ovary
samples (Fig. 3B).
EST analysis
The sequences derived from the 15K NIA and RIKEN
databases (see previous section) were mapped onto two
mouse EST libraries, from newborn ovary (7773 sequences,
NIA; Tanaka et al., 2000) and fertilized oocytes (library
#10029; 12,736 sequences, NIA; Sharov et al., 2003) (all
sequences available at www.ncbi.nlm.nih.gov/UniGene).
The relative abundance of the EST sequences and the
associated statistical differences were calculated (Audic and
Claverie, 1997); the differentially expressed hits compared to
the microarray data for equivalent tissues are given in Table 3.Public microarray data
Microarray data on RNA expression levels across a wide
range of adult mouse tissues are publicly available (Su et al.,
2002). They include ovary, uterus, oocytes, and fertilized
eggs. We reasoned that some genes with high expression in
somatic cells of the ovary could be recognized by a high
signal intensity in both ovary and uterus combined with low
expression in two female germ-line samples, referred to
global median intensity across all tissues tested (available at
http://symatlas.gnf.org/SymAtlas/); 314 genes in the NIA
15K set satisfied the criteria. About 22% of them (70/314)
were differentially expressed between newborn and adult
ovary (Table 4), as expected from the overall representation
of differentially expressed genes (2247/9582). This list
provided candidates for somatic lineage transcripts (see
Results).
Analysis of RLTR10 repeat family
The H3146E11 transcript sequence was used as a query
in wu-blastn (blast.wustl.edu, version 2.0) searches against
public EST databases, and EST clones from ovary and
oocytes (n = 111) were selected among the total hits
displaying over 94% identity for alignments longer than 200
bp (n = 186). The ovary/oocyte-derived H3146E11-related
EST clones were unambiguously mapped onto at least 11
distinct locations on the mouse genome, based on either
perfect nucleotide matching or unique gene sequences
Fig. 2. Northern blots of a sample of genes detected in one or both ovarian stages by microarray. (A) Dazl (H3121F04); (B) the C2H2 zinc-finger Teashirt-2
(H3083E07,H3147C07); (C) a novel CCHC zinc-finger (H3123C09); (D) a novel PHD-bromodomain (H3059E09); (E) Dek protooncogene (H3138A12); (F) a
novel leucine rich repeat-domain (H3127G07); (G) a novel myb-domain (H3029C12); (H) a member of a novel retrosequence gene family, RLTR10
(H3146E11).
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not shown). The total number of genomic RLTR10s was
derived from the February 2002 mouse genome sequence,
based on RepeatMasker annotations (genome.uscs.edu). The
minimal number of nonexcised sequences belonging to this
family was estimated by the minimum number of matches
N90% identical over N450 nt to internal (i.e., non-LTR)
portions of the H3146E11 clone obtained by wu-blastn
searches of the mouse genome with overlapping 500-nt
segments of H3146E11 as queries. We searched forpotential autonomous RLTR10 retrotransposons by similar
blastn analyses using the entire internal sequence as query;
we did not detect matches containing significantly longer
sequences, which would suggest a conserved pol-gag ORF.
Experimental validation
RT-PCR
One-step quantitative real-time RT-PCR with Taqman
probes and primers (ABI Prism 7700 Sequence Detection
Fig. 3. Differentially expressed genes classified according to Gene Ontology terms (A) and INTERPRO domains (B) with significantly different representation
between adult and newborn ovary. Light color bars, newborn ovary; dark color bars, adult ovary.
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Table 4
Genes preferentially expressed in somatic cell types of newborn (A) or adult ovary (B), inferred from microarray data as in Web Tables 2 and 3 combined with
published microarray results (median analysis, see Methods)
NIA clone ID Average score Gene symbol Annotations
A. Inferred genes preferentially expressed in somatic cells of the newborn ovary
H3116G07 10.4 Tm4sf6 Transmembrane 4 superfamily member 6 (Tm4sf6)
H3140D04 10.1 Lztr1 Leucine-zipper-like transcriptional regulator, 1
H3116D11 9.15 Cox7a2 Cytochrome c oxidase, subunit VIIa 2
H3140D05 8.2 Enpp5 Ectonucleotide pyrophosphatase/phosphodiesterase 5
H3130B04 7.55 Nicn1 Nicolin 1, mammalian-specific nuclear protein
H3140F05 6.35 Wfdc1 Whey acidic protein, core region Prostate stromal protein PS20
H3126F01 6.25 Plexin A2 Semaphorin/plexin repeat
H3082F02 6.1 2310014B11 Guanine nucleotide exchange domain
H3142A02 5.35 Ppp2cb Protein phosphatase 2a, catalytic subunit, beta isoform
H3119E02 5.25 4931406N15 PMMLP homolog; IPR005844 IPR005845 Phosphoglucomutase/
phosphomannomutase alpha/beta/alpha domain I and II
H3147B01 5.25 Tyro3 Protein tyrosine kinase 3 (Tyro3)
H3140D08 4.55 Fkbp1a FK506 binding protein 1a (12 kDa); Peptidylprolyl isomerase,
FKBP-type; ABC transporter
H3124A02 4.5 Ptn Pleiotrophin, containing PTN/MK heparin-binding domain
H3023E01 4.4 Tceb1l Transcription elongation factor B (SIII), polypeptide 1 (15 kDa), -like
(Tceb1l)
H3117D04 4.4 Fmr1 Fragile X mental retardation syndrome 1 homolog (Fmr1)
H3121A04 4.3 Ppp1cb Serine/threonine protein phosphatase
H3121C02 4.15 Fstl1 Follistatin-like1 (Fstl)/TSC-36/Flik/FLRG; may antagonize activin
H3113F12 3.95 Prnp Prion protein
H3122G08 3.9 2310016C16 Glutathione peroxidase
H3075F12 3.7 Tem8 Tumor endothelial marker eight precursor
H3032E06 3.65 Tulp4 Contains domains: Tubby, SOCS C-terminal, G-protein beta, and
WD-40 repeat
H3031C01 3.4 Krt2–8 Keratin complex 2, basic, gene 8 (Krt2–8)
H3072A12 3.1 2810468K05 Similar subunit of nuclear pore complex NUP84
H3135C02 3 Lgals7 Galectin-7
H3002D11 2.7 C130026I10 Intron of Reticulon 4 gene
H3093E01 2.35 Rtn4 Reticulon 4 (Rtn4) (also expressed in oocytes)
B. Inferred genes preferentially expressed in somatic cells of the adult ovary
H3131C05 8.1 4930422J18 SPla/RYanodine receptor SSB-1 homolog
H3109G09 6.9 1500036F01 Contains IQ calmodulin-binding region
H3066D10 6.65 Prkar1a cAMP-dependent protein kinase regulator, type II (also H3145A03)
H3007E10 6.55 Ckb Creatine kinase, brain
H3030E10 6.5 Ctsb Cathepsin B
H3106G12 6.25 AI047808 Zn-finger, CCCH-type
H3135D11 5.95 Tpm2 Tropomyosin 2, beta (Tpm2) (other clone: H3002C07)
H3055C02 5.7 4930570C03 Uncharacterized spliced transcript
H3044D09 5.65 Scd2 Stearoyl-Coenzyme A desaturase 2 (other clone: H3025B03)
H3098A09 5.55 Epdm2-pending Ependymin related protein-2 mRNA
H3008A09 5.5 Arhb Ras homolog gene family, member AB
H3120G06 5.45 Tpm1 Tropomyosin 1, alpha (Tpm1)
H3008A01 5.25 Stx12 Syntaxin 12, contains SNARE domain
H3122D01 5.25 Nedd4 Neural expressed, developmentally down-regulated 4
(also in oocytes; other clone: H3104B06)
H3108C10 5.1 Mm.260347 Composite SINE repeats
H3056C12 5.05 Dst Dystonin; hemidesmosomal plaque protein
H3132G02 4.95 App/Mm.131766 Amyloid beta (A4) precursor protein
H3054E05 4.9 Rps27 Ribosomal protein
H3076C06 4.9 Mm.182249 Composite SINE repeat
H3134F06 4.9 Sparcl1 SPARC-like 1 (mast9, hevin)
H3113G03 4.8 Agrn Agrin
H3055D08 4.75 Cop1 Constitutive photomorphogenic protein, contain ring-type zinc finger
H3078H12 4.5 Sulf2-pending Sulfatase weakly similar to N-acetylglucosamine-6-sulfatase
H3106B04 4.45 Mm.27490 Transmembrane protein similar to CGI-40 protein
H3148G03 4.4 Dkk3 Dickkopf homolog 3; Wnt pathway
H3139A10 4.2 Ckap1 Tubulin-specific chaperone b/tubulin folding cofactor b; contains
CAP-Gly domain
(continued on next page)
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Table 4 (continued)
NIA clone ID Average score Gene symbol Annotations
B. Inferred genes preferentially expressed in somatic cells of the adult ovary
H3146E06 3.45 Mcam melanoma cell adhesion molecule (Mcam)
H3112A08 3.4 Matn2 Matrilin 2
H3115C09 3.35 Lpp Cytochrome c heme-binding site; Zn-binding protein, LIM
H3133C01 3.35 Sui1-rs1 Suppressor of initiator codon mutations, related 1
H3151G01 3.35 Sf3b1 Splicing factor 3b, subunit 1, 155 kDa
H3154A09 3.25 Fln1 Filamin a/filamin 1 endothelial actin binding protein abp x280 nonmuscle
H3155A05 3.2 Tuba2 Tubulin alpha 2 MGD|MGI:107804
H3028G03 3.15 Robo1 Roundabout homolog 1 (Drosophila)
H3148D05 2.95 Dcn Decorin, contains Cysteine-rich region and leucine-rich repeat
H3154H04 2.75 Aplp2 Amyloid beta (A4) precursor-like protein 2 (Aplp2)
H3153C09 2.55 Timp2 Tissue inhibitor of metalloproteinase 2
H3115G02 2.15 Cadh Cadherin
The average scores were obtained with Focus for the newborn to adult comparison (see Methods and WEB Tables 2 and 3).
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performed to confirm microarray results. PCR was for 40
cycles according to the manufacturer’s protocols. Reactions
were normalized to Gapdh (except RLTR10, H3146E11,
which was normalized with h-actin). Each set of reactions
included RT-minus or nontemplate samples to control for
nonspecific amplification. The forward primer, reverse
primer, and probe sequences were, for Tsh3, 5V-TCGCQ
GGGAGAAGCATCATG, 3 V-CGCTTGTTCCTCCGQ
GCTCTA, and GGCAGCTGCCTTTAACTCATC; for
Tsh2, 5V-TCGTGTTGGAGGCTGTAGAA, 3V-TCACCC-
GAACACTCTCA, and 5V-CAGAACTATTCQTTCATC-
CACGTCTGCTA; for Dazl , 5V-GTAGAAGTCTGTGQ
GACCGAA, 3V-TTAAGCACTGCCCGACTTCTTCTG,
and 5V-CAGACAAGAGACCACTGTCTGTATG; for Wnt4,
5 V- TGGGAAGGTGGTGACACAAG , 3 V-ATGC Q
CCTTGTCACTGCAAAG, and TGTATACGCCATCTCTT-
CAGC; for Mllt10 (H3076A09), 5V-GCAGATCCQ
CCATCAACAATC, 3V-GCTACAGGCCCAGTTTTATC,
and 5 V-TCCACTCCACACAGCTACCACCAA; for
Fstl1 (H3121C02), 5V-GCAGAATGAAACAGCCATCA, 3V-
AGGCACTTGAGGAACTCTTG , a nd 5 V-CCT Q
CTGTGTTGACGCCCTCATTG; for Sf1 (H3053B11),
5V-CAAGAGTTAGTGCTCCAGTTG, 3V-ACGAGGCTGT-
GGTTGTTCAG, and CGTCTGTCTCAAGTTCCTCATC;
for Pole4 (H3Q126A12), 5V-ATCGCAAAAGATGCQ
CTACTG, 3V-CAGQACCATCCAGCTCCACAA, and 3V-
CGAATTCATCCACAGCTTCTATTGCA; for Taf7l
(H3Q154D11), 5V-GGAAGCTTAACATAATGGAA, 3V-
TCATCTGGAGGGTGAATCCA, and 5V-AAAGCCT-
CAGCCTGGCACACCAA; for Podocalyxin (H3029C03),
5V-CTACTGTCGCCTGCATCTCA, 3V-GTGACCAGTTGT-
G A C T T C T G , a n d 5 V- T G T C C A G A G C C -
ACCAAAGTGCCAC; for RTLR10 (H3146E11), 5V-
TGATAACTCCCTGGGCATGT, 3 V- CCCGTC -
CTTGGGTGACAA, and 5 V-CCAACCTAAGACA-
GGGATCAAACCAATGC; for Piwil2 (H3149H10),
assay Mm005002383 (TaqManRGene expression as-
says, Applied Biosystems); for Nxf2 (H3145H01),
5 V-CCTCACGTTAAGATCCTGAA , 3 V-CCTTG-
CCATTCTGAAGATTTC, and 5V-CCTTCTGCAAC-TGCTTCTTGGA; for Tktl1, 5V-ATTATCACCGTGGAG-
GATCA, 3V-ACTACGAGGCACATCCATTA, and 5V-
AGCAGTCTCCATGGAGCCTAAC; for h-act in,
ACGGCCAGGTCATCACTATTG, CAAGAAGGAAGG-
CTGGAAAAGA, and CAACGAGCGGTTCCGAT-
GCCC; and for Gapdh , Rodent GAPDH control
reagents (VIC Probe) (Applied Biosystems). Real-time
PCR was performed with serially diluted RNA (1.5, 1.0,
0.50, 0.25, and 0.1 ng as template). Reaction mixtures
were at 958C for 3 min, followed by 40 cycles at 958C for
30 s, 628C for 45 s, and 728C for 1 min.
In situ hybridization
In situ hybridization was performed on paraformalde-
hyde-fixed samples either embedded in paraffin or frozen as
described previously (Wilkinson and Nieto, 1993). To
linearize the pSPORT 1 plasmid containing each cDNA
insert, 15 Ag plasmid DNAwas digested overnight with SalI
or NotI. DNA was purified by three phenol/chloroform
extractions followed by chloroform extraction and ethanol
precipitation. Sense- and antisense-labeled transcripts were
generated using 1 Ag of DNA and RNA polymerases (T7 and
SP6) according to the manufacturer’s protocols (Roche).
Signals were scored after 5–6 h in nitroblue tetrazolium and
5-bromo-4-chloro-3-indolyl phosphate. RLTR10, Gdf9, Del-
tex2, BicD2, and Zfp37 probes were derived from constructs
of the NIA cDNA library (Tanaka et al., 2000; GenBank
accession numbers BG087929, BG080778, BG076683,
BG080326, and BG080774).
Immunohistochemistry
Samples were fixed in either 4% paraformaldehyde-PBS
or Histochoice (Amresco, Ohio) and embedded in paraffin.
Sections were unmasked in citrate buffer and stained using
Dako LSAB2 system (peroxidase and DAB) or Alexa-dye
fluorescent secondary antibodies (Molecular Probes). Pri-
mary antibodies were as follows: mouse antihuman cyclin
D3 (Stressgen), goat anti-mouse c-kit (Santa Cruz), mouse
antihuman cytokeratin 18 (Chemicon), rabbit antihuman
PDGF receptor h (Upstate), and rat anti-mouse laminin A1
(Chemicon). Images in Figs. 5A–D and 6 were taken with
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coupled to a SpotR camera (Diagnostic Instruments,
Sterling Heights, MI). Images in Figs. 5E–F were taken
with a HiRes CCD camera and processed on a Deltavision
system v.5.10. All images were processed with Adobe
PhotoshopR v.8.0.
Northern blot analyses
FirstChoicek Northern blot mouse blot I (Ambion, Inc.,
Austin, TX) multiple tissue membranes were used with
probes labeled with the RediPrimek II labeling System
(Amersham Pharmacia) according to the manufacturer’s
protocol; comparable amounts of RNA in each lane were
confirmed with a h-actin control. About 100 ng of cDNA
was the template for each probe synthesis. The activity of
a-32P in each hybridization was 106 cpm. Templates for
probe synthesis were cDNA inserts from NIA mouse cDNA
libraries. All cDNA inserts were excised from plasmids with
NotI and SalI and reamplified by PCR before use. The
primers used were, for Dazl1 (H3121F04), 5V-GGGCTTCG-
GTCAAATTTGCTATG and 3V-GGTGGTGATAGGCTGG-
GAATG (250 bp); for C2H2 zinc-finger Teashirt-2
(H3083E07,H3147C07), 5 V-CGAAGAGGACACA-
GACTCTA and 3V-GAGGTCATCACTGAGTCCAA (135
bp); for novel CCHC zinc-finger (H3123C09), 5V-AGCG-
GAGGAGGAGTCACA and 3V-CACTTTCGTCTCCCTG-
GAAA (503 bp); for novel PHD-bromodomain
(H3059E09), 5V-GAGCAGGACCCCGAGAAGAA and 3V-
CGTTTGGGCTGCCAGACAAG (136 bp); for Dek proto-
oncogene (H3138A12), 5V-CTGACGATGCAAGTGTCTTC
and 3V-CTACTAGACTCATCTGACAG (470 bp); for novel
leucine rich repeat domain (H3127G07), 5V-GGACTTCTCT-
TAACAGTAC and 3V-CAGGCCAGGAGTTTTGACAC
(390 bp); for novel myb domain (H3029C12), 5V-AGTCAG-
GAGGGTGAGTCTGA and 3V-TGTGCATTTGGGTGCTT-
GAC (430 bp); for member of a novel retrotransposon gene
family, RLTR10 (H3146E11), 5’-TGATCAATA-
G AT C C T C G C T G T G a n d 3 ’ - T C G AT C -
CTCTCCAAATATCCAG (364 bp).Results
Based on the normalization and selection criteria outlined
in Methods, a total of 9582 transcripts showed significant
expression in at least one of the two stages of ovarian
development tested (WEB Table 1). Northern blot hybrid-
ization confirmed expression in adult ovary of a sample of
eight genes that were either known to be expressed at low
levels (Dazl, Fig. 2A) or were not previously reported in the
ovary (Tsh2 and Dek, Figs. 2B and E) or were novel/
uncharacterized (Figs. 2C, D, and F–H).
Using a sensitive statistical test (see Methods, Fig. 1 and
WEB Tables 2 and 3), we identified 2247 transcripts (2115
UniGene clusters) that were differentially expressed in
newborn compared to adult ovary. Mapping the full set ofprotein-encoding genes on the Gene Ontology database (see
Methods and Fig. 3A) suggested extensive functional
differences. They largely reflected a vast repertoire of genes
involved in regulating nuclear activity and cell–cell inter-
actions during morphogenesis in the newborn ovary and a
greater prevalence of growth-related processes in the adult.
Thus, genes associated with transcription regulation, ATP
binding, and intracellular signaling functions were enriched
in expression in the newborn ovary (Fig. 3A). The
distribution of INTERPRO protein domains (Fig. 3B)
showed an especially high number of clones encoding
RNA binding factors. In contrast, in the adult (Fig. 3A),
increased expression was seen for genes involved in growth-
related processes, including oxidoreductase activity and
protein biosynthesis (Fig. 3B). Table 2 lists a set of genes
with known or potential developmental roles that show
differences in expression levels between newborn and adult
ovary.
The analysis then proceeded with tests that validated the
microarray results and integrated them with complementary
data available in public databases, providing a list of genes
with different stage and cell specificity.
Validation
Standard and real-time RT-PCR results confirmed that
results were reliable for the preponderance of genes
detected. For example, of 12 genes tested, the relative
levels for three known to be expressed in ovary (Dazl, Wnt4,
Sf1) and seven that are novel or previously uncharacterized
in this organ (RLTR10/H3146E12, Piwil2/H3149H10,
Tktl1/H3045F08, Taf7L/H3154D11, Mllt10/H3076A09,
Podx/H3029C03, and Fstl1/H3121C02) were confirmed
(t test, P b 0.05; Fig. 4 and data not shown). Transcripts
assigned to only 2 of the 12 genes showed mean intensity
values that were not significantly different by real-time RT-
PCR (Pole4/H3126A12 and Tsh2/H3083E07; t test, P N
0.05). Further investigation of one of them, Tsh2 (Caubit et
al., 2000), indicates that the discrepant values likely reflect
further complexity in the results. The mean intensity
difference for Tsh2 was opposite that expected from
microarray data; but this could result from cross-hybrid-
ization with a paralogous gene (Tsh3, N200 nt with 79%
identity over the cDNA clone H3083E07). Consistent with
this possibility, Tsh3 expression in the ovary showed a
mean intensity fold ratio reversed compared to Tsh2 (WEB
Fig. 1).
An independent computer-assisted analysis of redundant
clones present in the 15K microarray showed a comparable
result: under the stringent assumption that all UniGene
clusters contained truly coexpressed sequences (i.e., no
differentially expressed isoforms or inclusion of more than
one gene in an entry), 80% of the genes detected were
concordantly assigned among the clones detected.
Additional transcripts were studied by in situ hybrid-
ization or immunohistochemistry, including four controls
Fig. 4. Histograms representing relative mean expression values and standard deviation for 12 probes by real-time PCRs ( y-axis). From left to right: newborn
ovary, adult ovary (8 weeks) and adult testis. Values were normalized to GAPDH mean expression.
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previously uncharacterized or unreported in the ovary
(RLTR10, Dtx2, BicD2, Zfp37, Fig. 5 and data not shown).These data provide independent experimental validation of
the microarray analysis and are discussed in greater detail
below.
Fig. 5. Immunohistochemistry of newborn ovary enriched genes. CyclinD3
is expressed in somatic cells (A, white arrowhead) but not oocytes (A, black
arrowhead) before follicle formation, then it extends to oocytes as
primordial follicles form (B, black arrowhead) and is progressively lost
in growing follicles (B, white arrowhead) of the maturing ovary. CK18 is
expressed in ovarian surface epithelium (black arrowhead) and pregranu-
losa cells that infiltrate the oocyte clusters in the newborn ovary (C). C-kit
is expressed preferentially at the membrane of primordial and early primary
follicles (D, black arrowhead) and lost at the secondary follicle stage (white
arrowhead). Counterstaining for A-D: hematoxylin. PDGFR-h is detected
in stroma and vessels of newborn ovary (E, green), partly coincident with
follicle formation (white arrowhead shows fragmentary basal lamina
detected by anti-laminin A1 antibody, red). In the maturing ovary, it
persists selectively in theca interna of healthy follicles and some vessels
(white arrowheads), but not interstitial glands (white arrow) or atretic
follicles (asterisk). Scale bars: 20 Am.
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Even in the absence of information assigning individ-
ual genes to particular cell types, whole organ expression
profiling can help to investigate complex time-related
differences that are difficult to model in vitro. In addition,
the approach is directly justified for genes that are
expressed either in several cell types simultaneously or
in complex sequential patterns, but preferentially at a
particular stage. For instance, cyclin D3 (H3041D11),
which was correctly assigned as enriched in newborn
ovary by the microarray analysis, is expressed in fetal and
newborn pregranulosa cells, then appears in oocytes at the
time of primordial follicle formation, and is then down-
regulated in both oocytes and granulosa cells during
follicle growth (Zhang et al., 1999, and confirmatory
Figs. 5A–B).
Other markers of early ovarian differentiation include
cytokeratins (CK18, CK19, and CK8, Appert et al., 1998),
the clones for which were all correctly found enriched in thenewborn ovary (H3022G09, H3021B02, H3007G06,
H3031C01, H3036G12, H3104F03, and confirmatory data
for CK18 in Fig. 5C). These data suggest that some of the
uncharacterized transcripts identified in our study may
similarly show stage-specific expression in the ovary. For
other genes, however, whole organ gene expression differ-
ences rather reflect relative changes in cell-type composi-
tion. We addressed this possibility as follows.
Cell type-specific expression patterns
Cell type-specific expression data are available for adult
ovary and usually not for newborn ovary, largely for
technical reasons. However, we combined information from
NIA EST libraries and publicly available microarray data to
generate a partial list of genes enriched in oocytes (Tables
3A–B) and in somatic cells (Tables 4A–B) (see Methods
and Results below). We were thus able to compare changes
in gene expression levels with variations in cell type
numbers that accompany ovary development (Sforza et al.,
1993). In particular, as the ovary matures, the volumetric
fraction of oocytes and granulosa cells from small follicles
goes down, while stroma, steroidogenic cells (of both
stromal and granulosa origin), and vessels go up. In rodents,
these variations are particularly marked, because primordial
follicle formation occurs largely within a restricted window
of time around postnatal day 2 (e.g., Peters, 1969; Rajah et
al., 1992). Ovarian histogenesis and maturation are thus
discretely phased. Consequently, oocyte-specific and small
follicle-specific genes are expected to be considerably
enriched in the newborn ovary, and steroidogenic and
endothelial genes in the adult. In particular, a gene enriched
in adult (ovulated) oocytes compared to adult soma and
enriched in newborn compared to adult ovary is likely
oocyte specific throughout ovarian development (Table 3A).
Conversely, a gene enriched in ovary compared to oocytes
(see Methods), as well as in the adult ovary compared to the
newborn, is likely associated with somatic cells involved in
follicle growth (Table 4B).
Microarray data on stage specificity are particularly
informative when variations in gene expression patterns
contrast with those expected from the associated cell type,
because such contrasting patterns are directly suggestive of
a stage-specific role. For instance, genes specifically
expressed in oocytes and involved in oocyte growth were
found to be enriched in the adult, in spite of the relatively
small number of oocytes compared to organ size at this
stage (e.g., Gdf9 (H3056F01), Bmp15 (H3056A05), and
Zp3 (H3102C08); and novel genes in Table 3B, and Figs.
5C and E–F). Conversely, when they are enriched in
newborn ovary, genes from steroidogenic, stroma, and
vascular cells are candidates for a role in primordial follicle
formation or maintenance. In this case, the few genes
reported with such an expression pattern in ovary (e.g.,
NGFR, Dissen et al., 1995) were not available on the
microarray. However, we have identified genes belonging to
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(Podocalyxin , Agtr2, PDGFRb, see below). Inferred
markers of early differentiation of somatic lineages are
given in Table 4A. These genes were studied further, as
follows.
Cell type-specific transcripts enriched in newborn ovary:
known genes
Two genes of central importance for ovarian deve-
lopment were enriched in the newborn ovary: c-kit
(H3136A01, consistent with a reported 2-fold decrease in
mRNA expression in growing oocytes, Manova et al., 1990;
and Fig. 5D) and Wnt4 (H3121F01) (confirmatory data in
Fig. 4). These genes are expressed in different cell types
(predominantly in oocytes or granulosa cells, respectively),
but are both associated with severe phenotypes affecting
perinatal ovarian differentiation (c-kit, Matsui et al., 1990;
Wnt4, Vainio et al., 1999).
Germ cell-specific genes enriched in newborn ovary
show more uniform expression in oocytes throughout
ovary maturation, including Dazl (H3121F04, H3132H08,
Fig. 4), expressed in oocytes at all follicle stages and
required for progression through meiotic prophase in both
sexes in the mouse (Ruggiu et al., 1997); Nobox
(H3157G03), required for early oocyte growth and oocyte
maintenance (Rajkovic et al., 2004); Mater (H3102E07,
Tong and Nelson, 2000), a maternal effect gene expressed
from oocytes at all follicle stages; and Zfr (H3076B02),
encoding a zinc finger RNA binding protein with highest
levels in prophase I germ cells (Meagher et al., 1999).
Taken together, these data suggest that genes identified as
newborn ovary enriched by the microarray analysis are
candidates for functions in primordial follicle formation
and/or early follicle differentiation.
Cell type-specific transcripts enriched in newborn ovary:
novel protein-encoding genes
The list of oocyte-enriched genes included genes not
previously reported in the ovary but with known roles
highly suggestive of enrichment in oocytes. One example is
the checkpoint kinase 1 homolog (H3092A01) that is highly
expressed in meiosis I mouse spermatocytes. Chek1 encodes
a protein that colocalizes with Atm (OMIM607585),
associated with arrest in meiotic prophase in both sexes
when mutated (Flaggs et al., 1997). Similarly, the LAP/PHD
finger Mllt10/AF10 (H3076A09) and the TATA-binding
protein associated factor Taf7L (H3154D11) (both con-
firmed by real-time RT-PCR as stronger in newborn ovary,
Fig. 4) were reported as nearly testis specific (Linder et al.,
1998; Pointud et al., 2003), but are more likely present in all
germ cells.
The list of somatic genes enriched in the newborn (Table
4A) included a glycoprotein containing a follistatin-like
domain that can imitate follistatin effects in embryonic axisinduction but had not been reported in the ovary (Flst1/Flik/
TSC-36, Patel et al., 1996; Shibanuma et al., 1993,
confirmed by quantitative RT-PCR, Fig. 4). Other genes
were known to be expressed in the ovary, but their
developmental expression pattern is still poorly character-
ized. They included the fragile X syndrome gene Fmr1,
associated with premature ovarian failure in humans and
reported to be highly expressed in granulosa cells (Hergers-
berg et al., 1995). In addition, the enrichment in the
newborn of a lectin known to be specific to ovary and
adult-stratified epithelia (Galectin-7, Magnaldo et al., 1998,
confirmed by RT-PCR in data not shown) may be of interest
with regard to the epithelial origin of pregranulosa cells
(e.g., Rajah et al., 1992).
Vascular markers were identified on the basis of gene
annotations and lists of genes available in expression
profiling reports (Ho et al., 2003; Huminiecki and Bicknell,
2000). Two genes previously uncharacterized in the ovary
were found to be enriched in newborn. One is highly specific
for early events of developmental vasculogenesis and is
later expressed in podocytes (podocalyxin, H3029C03;
Hara et al., 1999; confirmed by real-time PCR, Fig. 4);
another is upregulated during fetal angiogenesis with
restricted expression pattern in adults (Agtr2, or angioten-
sin II receptor type 2, H3125F10, de Gooyer et al., 2004;
Kakuchi et al., 1995). Both are associated with urinary
tract anomalies leading to neonatal lethality when inacti-
vated (Doyonnas et al., 2001; Nishimura et al., 1999), and
they may have a comparably important function in ovarian
development. In a similar way, traditional stromal markers
in newborn ovary included a gene (H3140C02, PDGF
receptor-b) that is also involved with urogenital mor-
phogenesis (Puglianiello et al., 2004). We verified that
PDGFR-h is detected in most stroma and some endothelial
cells of the newborn ovary, around newly formed follicles,
primary follicles, and in a few cells that intercalate oocyte
clusters, often coincident with laminin deposition (by
double staining with specific antibodies, Fig. 5E). In the
maturing ovary (Fig. 5F), it is still high in some vessels, in
the residual cortical stroma, and then confined to theca
interna cells of some healthy follicles up to the antral stage.
In contrast, most of the stroma and all nonstromal cells are
negative or very faintly positive. This is consistent with
upregulation in the newborn and suggests an early role for
PDGFR-b in the differentiation of ovarian stroma.
Cell type-specific transcripts enriched in newborn ovary:
untranslated transcripts expressed in oocytes of primordial
and primary follicles
Among the transcripts not previously known to be
expressed in oocytes and/or granulosa cells of small
follicles, we identified a large number of retroviral-like
sequences and other repeats (36% [814/2247] of the clones
contained sequence repeats; WEB Tables 2 and 3). Several
of them were differentially expressed between newborn and
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expression of this class within the ovary and between ovary
and testis (see Discussion). They included a large number of
clones representing a novel retrosequence family (RLTR10)
(H3146E11 and others) that was 20- to 100-fold more
expressed in newborn ovary (Figs. 3–5 and data not shown).
In situ hybridization of the probe to sections of the ovary
showed strong expression in germ cells of the nascent
primordial and primary follicles in the newborn (Fig. 6A).
In corresponding sections of adult ovary, a gradient in
expression can be seen in follicles at various stages of
maturation (Fig. 6B). In the same series, diffuse expression
in granulosa cells lying nearest the oocyte may represent
bleakageQ from the oocyte (Canipari, 2000).
The cDNA clone is essentially identical to a ~2.8 kb
genomic retrosequence on mouse chromosome 12 flanked
by long terminal repeats (LTRs) of the RLTR10 class
(www.girinst.org/Repbase_Reports.html). The internal se-
quence displays three short segments of significant sim-
ilarity to classical IAP retrosequences (e.g., in accession
numbers M17551 and M73818), in a novel murine repeat
family (schematically aligned with several cloned variants
in WEB Fig. 2). No significantly similar sequence is
detected in the human genome. H3146E11 has the size
and sequence hallmarks of nonautonomous, internally
truncated retrosequences that are thought to be occasionally
generated from canonical ~6kb IAP-like elements (reviewedFig. 6. mRNA in situ hybridization for genes enriched in the newborn ovary
(A and B) and in the adult (C–F). The RLTR10 retrosequences show strong
signals in oocytes of nascent follicles in the newborn ovary (A). The signals
persist in primordial (white arrow) and primary follicles (black arrow) in the
adult, but are lost in growing follicles (B). The transcripts of Deltex (C),
Gdf9 (D), BicD2 (E), and Zfp37 (F) are detected only in growing oocytes.
Scale bars: 40 Am.by Kuff and Lueders, 1988). We failed to detect full-length
IAP sequences having high similarity to H3146E11, but
about 3800 sequences contain this class of LTRs. In
addition, we observed many sequences similar to internal
portions of H3146E11; about 500 loci show N95% identity
over at least 250 nt and ovary/oocyte-derived ESTs can be
assigned to at least 11 distinct RLTR10 loci (see Methods).
Therefore, the H3146E11 transcript proved to represent a
whole family of sequences, all relatively specific for germ
cells of nascent follicles, with some expression observed in
some granulosa cells of mature follicles.
Cell type-specific transcripts enriched in adult ovary:
known genes
In maturing ovary, we did not attempt to distinguish
specific regulators of follicle maturation from genes
essentially associated with expansion of adult cell types,
although data on known oocyte-specific genes were con-
sistent with our prediction (for example, Gdf9 and Bmp15;
Fig. 5H and data not shown). Markers of ovarian follicle
growth were not confined to oocytes but were also enriched
in the somatic compartment. This would be expected from
the estimated 21 doublings of granulosa cells during follicle
growth, with the basal lamina at the interface with stromal
theca cells increasing 219-fold (Rodgers et al., 2001). More
abundant expression of general basal lamina components in
the adult ovary thus included Col4a1 (H3159G06) and
Col4a2 (H3138E02).
Markers for growing follicle cells also showed higher
levels in adult ovary (e.g., InhibinA (H3142C10), Drum-
mond et al., 1996, and Foxo1 (H3065B05 and H3100B07),
Shi and LaPolt, 2003). In addition, the adult ovary gene set
included all relevant steroidogenic regulators and enzymes
that are expressed in luteal cells and adult stroma (including
steroidogenic factor SF1 (H3053B11, confirmatory data in
Fig. 4), which regulates transcription of all cytochrome
P450s; P450ssc/Cyp11A1 (H3094D01), catalyzing the
conversion of cholesterol to pregnenolone; steroidogenic
acute regulatory protein StAR (H3097G04), which regulates
accessibility of cholesterol to P450ssc; P450c17/Cyp17
(H3018A11), a theca cell marker that catalyzes the
formation of dehydroepiandrosterone (DHEA) and is
upregulated by Gdf9 in preantral follicles (Vitt et al.,
2000); and two clones (H3059B01, H3070C08) for pla-
cental 3-h-hydroxysteroid dehydrogenase Hsd3b1 (see
OMIM109715)). Interestingly, consistent with its role as a
repressor of P450c17/Cyp17 (Shibata et al., 2003), the C4-
type zinc-finger Coup-TF2 was upregulated at birth
(H3124H07). In addition, adult ovary showed an enrich-
ment of ubiquitous vascular markers, consistent with
massive cyclical angiogenesis as a feature of the mature
ovary. They included Selectin [Selel/Mg160, H3052F04],
C1qr1 [H3146C06], Pecam [H3052F06], and Eg1
[H3017G10] Liu et al., 2002 Yamaguchi et al., 2003).
Finally, novel genes expressed in oocytes showed expres-
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as follows.
Cell type-specific transcripts enriched in adult ovary:
novel genes
In spite of the small volume of oocytes in the adult ovary,
microarray analysis detected transcripts expressed only in
growing oocytes. The combined usage of microarray
information with NIA EST library data (see Methods)
detected both well-known genes upregulated in growing
follicle oocytes (Gdf9 and Bmp15) and also additional genes
previously uncharacterized (Table 3B). In situ hybridization
verified the results for three that were not previously
characterized. One, BicaudalD2 (H3054C10; low expres-
sion by ISH in Fig. 6, consistent with EST counts, Table
3B), a cytoplasmic-helical coiled-coil protein involved in
microtubule polarization, is orthologous to a Drosophila
gene essential for the establishment of oocyte identity and
embryonic axis polarization (Hoogenraad et al., 2001 and
references therein). A second, Zfp37 (H3056E09; confirmed
by ISH in Fig. 6), a C2H2 KRAB zinc finger gene, is also
highly expressed in the adult testis, with highest abundance
during late spermatogenesis and spermiogenesis (Burke and
Wolgemuth, 1992; Mazarakis et al., 1996). The third
example, Deltex2 (H3004E12; confirmed by ISH in Fig.
6), is a cytoplasmic SH3-ringH2 protein that mediates Notch
receptor signaling (Kishi et al., 2001).
Finally, microarray data suggest that additional genes that
are downregulated in female germ cells compared to ovary
and uterus (inferred by comparison to published data,
as above) are likely expressed in growing follicle cells
(Table 4B).Discussion
The overall census of about 9000 cDNAs significantly
active in the ovary extends earlier results with cultured
follicles or granulosa cells, which included the identification
of verified or inferred targets of critical ovarian determinants
(Burns et al., 2001; Dong et al., 1996; Rajkovic and Matzuk,
2002; Vanani et al., 2002) and two pilot microarray analyses
that showed 15 of 588 known genes changing in level
during late follicle maturation (Liu et al., 2001) and a
comparable number of changes in follicles from women
with full vs. depleted complements (Chin et al., 2002).
Selective expression in female gonads has, however,
been inferred for only a few genes (for example, the
homeobox gene Emx2, OMIM 600035, Pellegrini et al.,
1997; and nuclear steroid hormone receptor-related factor
Dax1, OMIM 300200, 300018). Pilot comparative screen-
ings for embryonic gonadal genes have been carried out
based on ESTs (Takasaki et al., 2000) or clone arrays
(Grimmond et al., 2000); by high-throughput in situ
hybridization (Wertz and Herrmann, 2000); or by cDNAdifference sampling (Perera et al., 2001). But those studies
detected mainly a number of testis-specific genes, whereas
genes for early stages of ovarian development were poorly
represented. In a review, Koopmann et al. (2002) even
questioned whether organ-specific transcriptional activity in
the ovary could be systematically detectable by microarrays;
but our findings show that time- and cell type-dependent
markers and pathways are definable for ovary as in other
developmental models.
Using whole organ preparations for microarray analysis
provides information on cellular interactions and pro-
cesses—in this case, follicle formation and maturation with
regulated control of quiescence and growth—for which no
in vitro model is currently available. In addition, taking into
consideration variations in cell populations that take place
with ovary maturation, this design permitted us to confirm
cell type-specificity in newborn ovary or to suggest stage
specificity for cell type-specific genes in newborn or adult
(see Results). Finally, the restricted time interval of follicle
development in the murine ovary enabled us to sort out
genes with selectively high expression in primordial and
early growing follicles (high in newborn ovary) from genes
enriched in growing follicles (high in adult ovary).
Although the microarray analyses cannot readily distinguish
between changes in cell population sizes and changes in
expression levels within a differentiating cell lineage (see
above), further experiments and independent sources of
evidence permitted the discrimination of genes that were
expressed throughout oogenesis from others selectively
involved in primordial follicle development or maintenance
(see Results).
cDNAs that showed differential expression as a function
of development or follicle differentiation were of particular
interest. EST correlations provided a list of oocyte-specific
genes with differential expression at different stages of
folliculogenesis. Similarly, a whole organ approach provid-
ing a useful entry to characterizing primordial follicle
formation, a notoriously complex morphogenetic process
involving different cell types, can be usefully characterized
starting with a whole-organ approach. The analysis, based
on standard pathways and in situ hybridization studies,
begins to suggest correlated gene functions for distinct
processes taking place at the same time in newborn ovary. In
particular, we detected several keratin genes downregulated
in adult ovary as well as several known and previously
unreported transcripts specific for primordial and small
growing follicles. They included examples expressed in
oocytes (c-kit, RLTR10), in granulosa cells (Wnt4), or in
both (cyclin D3). In addition, coordinated changes in
developmentally relevant gene pathways permitted us to
! identify several genes enriched in oocytes at different
follicle stages (Table 3), including a member of the
Notch pathway (Dlx2) and a transcription factor with
oocyte-specific functions in the fruit fly (BicD2)
(Figs. 6C–F);
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sion (Table 4), including some that are possibly
associated with the morphogenetic mechanisms involv-
ing migrating stromal and endothelial cells during
newborn ovary septation (Rajah et al., 1992) (notably
Podxl, Fig. 4; and PDGFR-h, Figs. 5E–F); and
! reveal a striking enrichment of retrotransposon-related
sequences in the newborn ovary (RLTR10, Figs. 4 and
6A–B, and WEB Fig. 2).Novel noncoding repeat family
The new, nonautonomous repeat family represented by
H3146E11 is highly expressed in the oocytes of primordial
and primary follicles, and at lower levels in granulosa
cells of multilayered follicles. The probe likely detects a
large fraction of the many loci that show extensive
similarity to H3146E11 (see Results). It is therefore striking
that the observed hybridization signal is highly tissue and
stage specific. The data indicate that this does not reflect
massive expression of one or a few loci, but rather coex-
pression of many members of the gene family in newborn
ovary.
Though their genomic distribution and context have not
been analyzed in detail, some other transposons have been
reported to show gonad-specific expression. LINE-1s, for
example, are expressed in developing spermatogonia and
ovarian cells but not in peri-implantation embryos (Trelogan
and Martin, 1995); and IAP sequences and some HERV-K
elements are expressed in sperm precursors but not in the
ovary (Casau et al., 1999; Dupressoir and Heidmann, 1996;
Ono, 1986). Specificity for ovary has also been reported for
some VL30 (Schiff et al., 1991), partially characterized LTR
cDNAs (Goto et al., 1999, 2002), and one rat IAP (bIAP-
LEQ, for IAP-like element) expressed in granulosa cells of
primary follicles (Graham et al., 2000); its LTR elements
show 74% identity to the class reported here and may
represent a related class.
There has been a tendency to rationalize the expression of
such sequences as simply indicating bpermissivenessQ of
transcription in gonadal tissues, but the results rather in-
dicate that transcription is not bgeneralQ or bpromiscuousQ,
but can be restricted to specific subgroups or classes of
sequence, gonadal types, and even stages of development.
One possibility is that such retrosequences could be merely
carried along as bselfish RNAQ. Alternatively, elements like
those joined to downstream exons of genes (WEB Fig. 2)
may operate to regulate development by inhibiting tran-
scription, as reported for other retrotransposon elements
(reviewed by Brosius, 1999).
Suggestively, one recently described human-specific
LTR retrotransposon family expressed in oocytes (though
at all stages rather than primarily early on) was correctly
transcribed in oocytes in transgenic fish (Pi et al., 2004).
Dissection of the determinants of repeat sequence tissue
specificity may help to explain the regulation of suchRNAs and of coding RNAs with similar promoter
elements.
Prospects for further analysis
Some genes represented on the microarrays and known
to be differentially expressed by published reports (e.g.,
H3005C08, Laminin a5; Frojdman et al., 1999) or by
inference from EST analysis and confirmed by us (data not
shown) were not scored as significant. Also, other well-
characterized factors known to be specifically required for
newborn ovary histogenesis (NGFR, TrkB, NGF, NT4, e.g.,
Dissen et al., 2001; Spears et al., 2003) were absent from the
15K array. These deficiencies should be remedied as genes
expressed below a threshold value, which have been
conservatively excluded, are accurately quantitated with
novel technologies (reviewed by Lam and Renil, 2002), and
microarrays are used that incorporate more complete gene
cohorts.
Thus far, only some of the genes differentially expressed
in microarray analyses could be assigned to specific cell
types or processes. The assignments could be augmented as
EST libraries add more differential expression data. In
addition, further fractionation of developmental steps of the
immature ovary could be used to assess expression at
different follicle stages (similar to the analysis of stages in
spermatogenesis in the prepubertal testis; Fujii et al., 2002).
As gene annotations expand and smaller changes in
expression can be dependably determined, analyses can be
extended in important directions. First, apparent follicle
formation from embryonic stem cells in vitro (Hubner et al.,
2003) may offer a model for comparative studies of
development based purely on derived oocytes and granulosa
cells. Second, recent evidence suggests a possibly compa-
rable function of germ cells with stem cell-like character-
istics in regeneration of part of the follicle pool postnatally
(Johnson et al., 2004). It should be possible to determine
how much they contribute to follicle dynamics and how
much they depend on a bnicheQ that regulates growth.
Finally, for many instances of haploinsufficiency (like
FOXL2 lesions, in which mutation of one allele can result
in early menopause; Crisponi et al., 2001), functionally
relevant target genes and networks can be determined for
possible intervention in reproductive disorders.Acknowledgments
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